Back to MW MARSHALL WACE, LLP

NAUTNAUT
9 quarters

Position history for MWMARSHALL WACE, LLP's holdings in NAUTILUS BIOTECHNOLOGY INC

MARSHALL WACE, LLP holds 265,582 shares of NAUT (NAUTILUS BIOTECHNOLOGY INC), worth $496,639 as of 2026-Q2. The position was decreased (-17.0% shares). NAUT represents 0.0% of MARSHALL WACE, LLP's portfolio.

Current Value

$496,639

Current Shares

265,582

Total Value Change

-$182,361

Total Shares Change

+198,384

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
265,582
-17.0%
$496,6390.0%$1.87
0
2026-Q1
Increased
319,882
+173.3%
$1.2M0.0%$2.41
41
2025-Q4
New
117,059
-
$228,2650.0%$1.91
32
2022-Q3
Exited
0
-100.0%
$00.0%$2.14
0
2022-Q2
New
11,500
-
$30,0000.0%$2.64
27
2022-Q1
Exited
0
-100.0%
$00.0%$4.24
0
2021-Q4
Decreased
37,713
-77.3%
$195,0000.0%$5.35
0
2021-Q3
Increased
166,326
+147.5%
$1M0.0%$6.16
40
2021-Q2
New
67,198
-
$679,0000.0%$9.91
34

Other major holders of NAUT: RA CAPITAL MANAGEMENT, L.P., Alyeska Investment Group, L.P., BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used